For: | Rojas M, Chávez-Castillo M, Bautista J, Ortega Á, Nava M, Salazar J, Díaz-Camargo E, Medina O, Rojas-Quintero J, Bermúdez V. Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links. World J Diabetes 2021; 12(6): 745-766 [PMID: 34168725 DOI: 10.4239/wjd.v12.i6.745] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v12/i6/745.htm |
Number | Citing Articles |
1 |
Geetika Nehra, Bjoern Bauer, Anika M.S. Hartz. Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance. Pharmacology & Therapeutics 2022; 234: 108119 doi: 10.1016/j.pharmthera.2022.108119
|
2 |
Teresa Vezza, Víctor M Víctor. SIRT1 and miR-34a-5p: Valuable Biomarkers for the Early Detection of Cognitive Impairment in Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 2024; 109(7): e1546 doi: 10.1210/clinem/dgad740
|
3 |
Cong Li, Haifeng Qian, Lina Feng, Mingquan Li. Causal Association Between Type 2 Diabetes Mellitus and Alzheimer’s Disease: A Two-Sample Mendelian Randomization Study. Journal of Alzheimer's Disease Reports 2024; 8(1): 945 doi: 10.3233/ADR-240053
|
4 |
Fan Zhang, Melissa Petersen, Leigh Johnson, James Hall, Sid E. O’Bryant. Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer’s Disease in the HABS-HD Study. Journal of Alzheimer's Disease 2023; 96(4): 1529 doi: 10.3233/JAD-230755
|
5 |
Albert Joseph Sulangi, Sarah E Lyons, Amy A Abdou, Hemangi Patel, Deepika Nagliya, Eileen Joseph, Carmel Joseph, Divya Kumar, Shivani Patel, Isha Jinwala, Mayur S Parmar. Exploring the Therapeutic Potential of DPP4 Inhibitors in Alzheimer's Disease: Molecular Insight and Clinical Outcome. Cureus 2024; doi: 10.7759/cureus.72648
|
6 |
Ides M Colin, Lidia W Szczepanski, Anne-Catherine Gérard, Jose-Antonio Elosegi. Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer’s Disease. European Endocrinology 2023; 19(1): 16 doi: 10.17925/EE.2023.19.1.16
|
7 |
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, Katarzyna Wanke, Żaneta Kałuzińska-Kołat, Marta Aleksandrowicz, Renata Kontek. Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications. International Journal of Molecular Sciences 2024; 25(22): 11955 doi: 10.3390/ijms252211955
|
8 |
Keke Song, Rongrong Zhang, Xiaoqi Zhao, Lan Yang, Qiang Wang, Wei Gao. Perioperative neurocognitive disorder changes in elderly diabetes patients within 30 days after surgery: a retrospective cohort study. Aging Clinical and Experimental Research 2023; 35(12): 2911 doi: 10.1007/s40520-023-02583-9
|
9 |
Khaled Hameed Husain, Saud Faisal Sarhan, Haya Khaled Ali Abdulla AlKhalifa, Asal Buhasan, Abu Saleh Md Moin, Alexandra E. Butler. Dementia in Diabetes: The Role of Hypoglycemia. International Journal of Molecular Sciences 2023; 24(12): 9846 doi: 10.3390/ijms24129846
|
10 |
Tatiana Korolenko, Nina Dubrovina, Marina Ovsyukova, Nataliya Bgatova, Michael Tenditnik, Alexander Pupyshev, Anna Akopyan, Natalya Goncharova, Chih-Li Lin, Evgeny Zavjalov, Maria Tikhonova, Tamara Amstislavskaya. Treatment with Autophagy Inducer Trehalose Alleviates Memory and Behavioral Impairments and Neuroinflammatory Brain Processes in db/db Mice. Cells 2021; 10(10): 2557 doi: 10.3390/cells10102557
|
11 |
Haiyang Du, Xiaoyu Meng, Yu Yao, Jun Xu. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1033479
|
12 |
Kayalvizhi Rajendran, Uma Maheswari Krishnan. Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease. Ageing Research Reviews 2024; 97: 102309 doi: 10.1016/j.arr.2024.102309
|
13 |
Jiwei Jiang, Hanping Shi, Shirui Jiang, Anxin Wang, Xinying Zou, Yanli Wang, Wenyi Li, Yuan Zhang, Mengfan Sun, Qiwei Ren, Jun Xu. Nutrition in Alzheimer’s disease: a review of an underappreciated pathophysiological mechanism. Science China Life Sciences 2023; 66(10): 2257 doi: 10.1007/s11427-022-2276-6
|
14 |
Rima Pramanik, Anuradha Dey, Anirban Kr Chakrabarty, Dipankar Banerjee, Avinash Narwaria, Swapnil Sharma, Rajiva Kumar Rai, Chandra Kant Katiyar, Sunil Kumar Dubey. Diabetes mellitus and Alzheimer's disease: Understanding disease mechanisms, their correlation, and promising dual activity of selected herbs. Journal of Ethnopharmacology 2024; 333: 118402 doi: 10.1016/j.jep.2024.118402
|
15 |
Richard Simon Machado, Khiany Mathias, Larissa Joaquim, Rafaella Willig de Quadros, Fabricia Petronilho, Gislaine Tezza Rezin. From diabetic hyperglycemia to cerebrovascular Damage: A narrative review. Brain Research 2023; 1821: 148611 doi: 10.1016/j.brainres.2023.148611
|
16 |
Nagwa M. Abdelazeem, Wael M. Aboulthana, Ashraf S. Hassan, Abdulrahman A. Almehizia, Ahmed M. Naglah, Hamad M. Alkahtani. Synthesis, in silico ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents. Saudi Pharmaceutical Journal 2024; 32(5): 102025 doi: 10.1016/j.jsps.2024.102025
|
17 |
Elizabeth M. Rhea, Manon Leclerc, Hussein N. Yassine, Ana W. Capuano, Han Tong, Vladislav A. Petyuk, Shannon L. Macauley, Xavier Fioramonti, Owen Carmichael, Frederic Calon, Zoe Arvanitakis. State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease. Aging and disease 2023; : 0 doi: 10.14336/AD.2023.0814
|
18 |
Hoda M. Moghazy, Nesreen G Abdelhaliem, Sherine Ahmed Mohammed, Asmaa Hassan, Amany Abdelrahman. Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model. Pflügers Archiv - European Journal of Physiology 2024; 476(5): 779 doi: 10.1007/s00424-024-02933-0
|
19 |
Toshiyuki Oshitari. Advanced Glycation End-Products and Diabetic Neuropathy of the Retina. International Journal of Molecular Sciences 2023; 24(3): 2927 doi: 10.3390/ijms24032927
|
20 |
Xin Yuan, Fei Yan, Li‐Hui Gao, Qian‐Hui Ma, Ju Wang. Hypericin as a potential drug for treating Alzheimer's disease and type 2 diabetes with a view to drug repositioning. CNS Neuroscience & Therapeutics 2023; 29(11): 3307 doi: 10.1111/cns.14260
|
21 |
Asmaa Embaby Sewillam, Zahra M Hasan Sry, Naguib A Salem, Ayat Allah Farouk Ahmed Hussein, Ahmed Essmat, Heba Ahmed Ali Abdeen. Effect of structured physical therapy program on patients with diabetes and mild cognitive impairment: randomised controlled trial. Physiotherapy Quarterly 2024; 32(2): 100 doi: 10.5114/pq/166622
|
22 |
Guglielmina Froldi. View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences. Pharmaceuticals 2024; 17(4): 478 doi: 10.3390/ph17040478
|
23 |
Keiko Shigemori, Sachiko Nomura, Tomohiro Umeda, Shuko Takeda, Takami Tomiyama. Peripheral Aβ acts as a negative modulator of insulin secretion. Proceedings of the National Academy of Sciences 2022; 119(12) doi: 10.1073/pnas.2117723119
|
24 |
Jessica E.B.F. Lima, Natalia C.S. Moreira, Elza T. Sakamoto-Hojo. Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2022; : 503437 doi: 10.1016/j.mrgentox.2021.503437
|
25 |
Enoc Mariano Cortés Malagón, Adolfo López Ornelas, Irlanda Olvera Gómez, José Bonilla Delgado. The Kynurenine Pathway, Aryl Hydrocarbon Receptor, and Alzheimer’s Disease. Brain Sciences 2024; 14(9): 950 doi: 10.3390/brainsci14090950
|
26 |
Renshi Li, Fengjie Zheng, Peichen Xu, Li Lv, Yapeng Mu, Xianghua Zhuang, Shihong Chen. Correlation of mild cognitive impairment with the thickness of retinal nerve fiber layer and serum indicators in type 2 diabetic patients. Frontiers in Endocrinology 2024; 14 doi: 10.3389/fendo.2023.1299206
|
27 |
Flavia Agata Cimini, Marzia Perluigi, Ilaria Barchetta, Maria Gisella Cavallo, Eugenio Barone. Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update. International Journal of Molecular Sciences 2022; 23(10): 5574 doi: 10.3390/ijms23105574
|
28 |
Sophia Nazir. Salivary biomarkers: The early diagnosis of Alzheimer's disease. AGING MEDICINE 2024; 7(2): 202 doi: 10.1002/agm2.12282
|
29 |
Ting Li, Hong-xia Cao, Dan Ke. Type 2 Diabetes Mellitus Easily Develops into Alzheimer’s Disease via Hyperglycemia and Insulin Resistance. Current Medical Science 2021; 41(6): 1165 doi: 10.1007/s11596-021-2467-2
|
30 |
Nathan R. Kerr, Chandler W. Mossman, Chih-Hsuan Chou, Joshua M. Bunten, Taylor J. Kelty, Thomas E. Childs, Randy Scott Rector, William David Arnold, Laurel A. Grisanti, Xiangwei Du, Frank W. Booth. Hindlimb immobilization induces insulin resistance and elevates mitochondrial ROS production in the hippocampus of female rats. Journal of Applied Physiology 2024; 137(3): 512 doi: 10.1152/japplphysiol.00234.2024
|
31 |
Anne Grosskopf, Jette Rahn, Ahyoung Kim, Gábor Szabó, Dan Rujescu, Frank Klawonn, Andrej Frolov, Andreas Simm. Peptide-Bound Glycative, AGE and Oxidative Modifications as Biomarkers for the Diagnosis of Alzheimer’s Disease—A Feasibility Study. Biomedicines 2024; 12(9): 2127 doi: 10.3390/biomedicines12092127
|
32 |
Sweta Priyadarshini Pradhan, Anindita Behera, Pratap Kumar Sahu. Effect of selenium nanoparticles conjugated Vildagliptin on cognitive dysfunction associated with Diabetes mellitus. Journal of Drug Delivery Science and Technology 2024; 98: 105907 doi: 10.1016/j.jddst.2024.105907
|
33 |
Laryssa Alves-Borba, Verónica Espinosa-Fernández, Ania Canseco-Rodríguez, Ana María Sánchez-Pérez. ABA Supplementation Rescues IRS2 and BDNF mRNA Levels in a Triple-Transgenic Mice Model of Alzheimer’s Disease. Journal of Alzheimer's Disease Reports 2023; 7(1): 1007 doi: 10.3233/ADR-230056
|
34 |
Yashika Arora, Anirban Dutta. Perspective: Disentangling the effects of tES on neurovascular unit. Frontiers in Neurology 2023; 13 doi: 10.3389/fneur.2022.1038700
|
35 |
Norhamidar Ab-Hamid, Norsuhana Omar, Che Aishah Nazariah Ismail, Idris Long. Diabetes and cognitive decline: Challenges and future direction. World Journal of Diabetes 2023; 14(6): 795-807 doi: 10.4239/wjd.v14.i6.795
Abstract(696) |
Core Tip(376) |
Full Article(HTML)(1829)
|
Full Article with Cover (PDF)-1108K(63)
|
Full Article (Word)-469K(20)
|
Audio-295K(3)
|
Peer-Review Report-216K(51)
|
Answering Reviewers-109K(41)
|
Full Article (PDF)-902K(171)
|
Full Article (XML)-171K(48)
|
Times Cited (8)
|
Total Visits (4529)
|
Open
|
36 |
Jiehui Chen, Yong Liu, Keru Zhou, Wei Zhang, Bin Wen, Kai Xu, Yazhou Liu, Ling Chen, Yue Huang, Benhong He, Weijian Hang, Juan Chen. DISC1 inhibits GSK3β activity to prevent tau hyperphosphorylation under diabetic encephalopathy. BioFactors 2023; 49(1): 173 doi: 10.1002/biof.1884
|
37 |
Ozra Tabatabaei Malazy, Fatemeh Bandarian, Mostafa Qorbani, Shahrzad Mohseni, Somayeh Mirsadeghi, Maryam Peimani, Bagher Larijani. The effect of metformin on cognitive function: A systematic review and meta-analysis. Journal of Psychopharmacology 2022; 36(6): 666 doi: 10.1177/02698811211057304
|
38 |
LaQuadria S. Robinson, Kristin D. Ashley, Tiffany Brown Ervin, Tina Smith, Loretta T. Lee. A Narrative Review of Alzheimer Dementia in African American and Hispanic Populations: The Health Care Provider's Role. The Journal for Nurse Practitioners 2024; 20(8): 105104 doi: 10.1016/j.nurpra.2024.105104
|
39 |
Zheng Shen, Zheng-Yang Li, Meng-Ting Yu, Kai-Leng Tan, Si Chen. Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains. Biomedicine & Pharmacotherapy 2023; 158: 114206 doi: 10.1016/j.biopha.2022.114206
|
40 |
Yanchun Li, Zhongyang Lu, Cameron L. Kirkwood, Keith L. Kirkwood, Stephen A. Wank, Ai‐Jun Li, Maria F. Lopes‐Virella, Yan Huang. GPR40 deficiency worsens metabolic syndrome‐associated periodontitis in mice. Journal of Periodontal Research 2023; 58(3): 575 doi: 10.1111/jre.13107
|
41 |
Xian-wen Ye, Meng-nan Liu, Xuan Wang, Shui-qing Cheng, Chun-shuai Li, Yu-ying Bai, Lin-lin Yang, Xu-xing Wang, Jia Wen, Wen-juan Xu, Shu-yan Zhang, Xin-fang Xu, Xiang-ri Li. Exploring the common pathogenesis of Alzheimer’s disease and type 2 diabetes mellitus via microarray data analysis. Frontiers in Aging Neuroscience 2023; 15 doi: 10.3389/fnagi.2023.1071391
|